iStent Trabecular Micro-Bypass: An exciting new glaucoma technology for patients requiring cataract surgery.
Today, almost every aspect of vision is connected to a product or procedure that was not available even ten short years ago. Today, this includes managing mild-to-moderate open-angle glaucoma: because now we are able to add another step to cataract surgery that allows us to treat open-angle glaucoma in a completely new way.
The world’s tiniest medical device - iStent - is 20,000 times smaller than the intraocular lenses (IOL) used in cataract surgery. This technology is designed to reduce the pressure caused by the buildup of fluid within the eye. Too much fluid raises pressure, which can cause the gradual loss of vision. And while glaucoma moves slowly, its damage is irreparable to your eye.
Leaving Glaucoma untreated can lead to blindness. There are different types of glaucoma with the most common type being open-angle glaucoma. Open-angle glaucoma causes damage to the optic nerve witch can result in vision lost and if left untreated - blindness.
Sadly, there is no cure for glaucoma, but there are both medical and surgical treatments to control your glaucoma. After an eye exam, an iStent may be the best possible solution to maintain your eye sight without further loss of vision.
The iStent is the smallest medical device ever approved by the FDA. It is so small, you won’t be able to see or feel it after surgery but it will be continuously working to help reduce eye pressure.
Proven safe and effective, the iStent Trabecular Micro-Bypass:
• High Success rates. Most patients benefit from iStent and see a reduction in their dependence on glaucoma medications.
• Safe and Effective. The procedure Spares important eye tissue that could be damaged by traditional surgeries. Also, iStent does not limit treatment options that could help maintain your vision in the future.
• Non-invasive treatment. Istent is safely implanted during cataract surgery. iStent procedure requires no additional incisions.
iStent is covered by Medicare and many private insurance plans. If you are going to have cataract surgery and are currently taking one or more medications to lower your eye pressure, you may be a candidate for iStent.
The Istent procedure is performed during cataract surgery. Once your cataract is removed the Istent device will be placed within the eye. You will not see or feel the istent within the eye.
After your treatment, you may be prescribed eye drops to help the recovery process. It is recommended to avoid excessive physical activity or activities that could buildup eye pressure.
For patients with both glaucoma and cataracts, iStent Trabecular Micro-Bypass stent is a new, FDA-approved surgical therapy that can significantly reduce eye pressure to help prevent vision loss. The iStent is placed in the eye during cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild to moderate open-angle glaucoma.
The iStent is the first device that improves the eye’s natural fluid outflow to safely lower eye pressure by creating a permanent opening in the trabecular meshwork. Controlling eye pressure is extremely important to reduce the risk for vision loss due to glaucoma. The primary cause of elevated intraocular pressure (IOP) in patients with open-angle glaucoma is a blockage of the trabecular meshwork. iStent is designed to create a permanent opening in your eye’s drainage system to improve the outflow of fluid from your eyes. By increasing fluid outflow, iStent lowers pressure within the eye.